Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer cell

Showing results (411-420 of 4,097) with videos related to

Pageof 410
Sort By:
Cancer Cell|June 27, 2020
Selective Inhibition of STRN3-Containing PP2A Phosphatase Restores Hippo Tumor-Suppressor Activity in Gastric CancerYang Tang, Gemin Fang, Fenghua Guo, et al.
Cancer Cell|August 1, 2020
Engineering CAR-T Cells for Next-Generation Cancer TherapyMihe Hong, Justin D Clubb, Yvonne Y Chen
Cancer Cell|July 4, 2020
SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling PathwaysHuairui Yuan, Ying Han, Xuege Wang, et al.
Cancer Cell|April 13, 2021
A rational targeted therapy for platinum-resistant small-cell lung cancerBenjamin J Drapkin, John D Minna
Cancer Cell|April 16, 2021
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacyChirag Krishna, Renzo G DiNatale, Fengshen Kuo, et al.
Cancer Cell|August 2, 2002
Alternative and aberrant splicing of MDM2 mRNA in human cancerFrank Bartel, Helge Taubert, Linda C Harris
Cancer Cell|September 21, 2002
Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeuticsAnthony Letai, Michael C Bassik, Loren D Walensky, et al.
Cancer Cell|September 21, 2002
Transforming properties of a Q18-->E mutation of the microtubule regulator Op18David E Misek, Christina L Chang, Rork Kuick, et al.
Cancer Cell|September 3, 2002
Fas function and tumor progression: use it and lose itLaurie B Owen-Schaub
Cancer Cell|September 3, 2002
Antiangiogenics meet nanotechnologyErkki Ruoslahti
Pageof 410

Showing results (411-420 of 4,097) with videos related to

Sort By:
Pageof 410
Cancer Cell|June 27, 2020
Selective Inhibition of STRN3-Containing PP2A Phosphatase Restores Hippo Tumor-Suppressor Activity in Gastric CancerYang Tang, Gemin Fang, Fenghua Guo, et al.
Cancer Cell|August 1, 2020
Engineering CAR-T Cells for Next-Generation Cancer TherapyMihe Hong, Justin D Clubb, Yvonne Y Chen
Cancer Cell|July 4, 2020
SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling PathwaysHuairui Yuan, Ying Han, Xuege Wang, et al.
Cancer Cell|April 13, 2021
A rational targeted therapy for platinum-resistant small-cell lung cancerBenjamin J Drapkin, John D Minna
Cancer Cell|April 16, 2021
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacyChirag Krishna, Renzo G DiNatale, Fengshen Kuo, et al.
Cancer Cell|August 2, 2002
Alternative and aberrant splicing of MDM2 mRNA in human cancerFrank Bartel, Helge Taubert, Linda C Harris
Cancer Cell|September 21, 2002
Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeuticsAnthony Letai, Michael C Bassik, Loren D Walensky, et al.
Cancer Cell|September 21, 2002
Transforming properties of a Q18-->E mutation of the microtubule regulator Op18David E Misek, Christina L Chang, Rork Kuick, et al.
Cancer Cell|September 3, 2002
Fas function and tumor progression: use it and lose itLaurie B Owen-Schaub
Cancer Cell|September 3, 2002
Antiangiogenics meet nanotechnologyErkki Ruoslahti
Pageof 410